✦ LIBER ✦

Emerging kinetics of BCR–ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure

✍ Scribed by Lee-Yung Shih; Ming-Chung Kuo; Ching-Yuan Kuo; Tseng-Hsi Lin; Li-Yaun Bai; Tsai-Yun Chen; Ming-Chung Wang; Tung-Liang Lin; Yii-Jenq Lan; Chih-Cheng Chen; Youngsen Yang; Pei-Ching Hsiao; Chang-Liang Lai; Chia-Hui Chang; Tung-Huei Lin

Book ID: 118132767
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 743 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2012.09.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of BCR-ABL mutations on response

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

✍ Mario Tiribelli, Roberto Latagliata, Luigiana Luciano… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 143 KB

Frequency and clinical significance of B

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

✍ Jabbour, E; Kantarjian, H; Jones, D; Talpaz, M; Bekele, N; O'Brien, S; Zhou, X; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Treatment of patients (PTS) with chronic

Treatment of patients (PTS) with chronic myeloid leukemia (CML) and imatinib failure after developing BCR-ABL kinase mutations with allogeneic stem cell transplantation (ASCT)

✍ E. Jabbour; J. Cortes; M. De Lima; B. Andersson; S. Giralt; H. Kantarjian; R. Ch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Quantitative molecular monitoring of BCR

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment

✍ Sara Galimberti; Giulia Cervetti; Francesca Guerrini; Rossana Testi; Simone Paci 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Off-target effects of BCR–ABL1 inhibitor

Off-target effects of BCR–ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia

✍ Steegmann, Juan Luis; Cervantes, Francisco; le Coutre, Philipp; Porkka, Kimmo; S 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 309 KB

Velocity of early BCR-ABL transcript eli

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

✍ Hanfstein, B; Shlyakhto, V; Lauseker, M; Hehlmann, R; Saussele, S; Dietz, C; Erb 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 599 KB